clinical pipeline rg 101 rg 012 rg 125 biomarkers platform about micrornas platform technology biology & pharmacology intellectual property news publications investors overview stock information historic stock lookup investment calculator analyst coverage ownership profile corporate governance management board of directors committee composition financials & filings sec filings annual reports quarterly results press releases events & presentations investor faqs contact us careers working at regulus current openings internships benefits keeping our rgls family healthy compensation and financial rewards time to recharge in the community contact together we ... together we believe that microrna therapeutics will become a major new class of drugs . we are focused on harnessing their power to target multiple pathways of disease . believe achieve there are no upcoming eventsat this time.check out the event archive oct06 regulus reports inducement grant under nasdaq listing rule 5635 c 4 tweets by regulusrx microrna moa 2016 regulus therapeutics inc. all rights reserved home legal contact menu about about management directors advisors history programs clinical pipeline rg 101 rg 012 rg 125 biomarkers platform about micrornas platform technology biology & pharmacology intellectual property news publications investors overview stock information historic stock lookup investment calculator analyst coverage ownership profile corporate governance management board of directors committee composition financials & filings sec filings annual reports quarterly results press releases events & presentations investor faqs contact us careers working at regulus current openings internships benefits keeping our rgls family healthy compensation and financial rewards time to recharge in the community contact